QUCY
What one share of Quantum Cyber holds
Pharmaceutical Preparations
In March 2025, we acquired a license from Liquid Bioscience, Inc. to access a portfolio of novel
Quantum Cyber’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$2.08 |
|---|---|
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$1.25 |
| Cash and investments | $1.37 |
| Book value | $2.08 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | $0.91 | −$21.91 | $0.11 | −$17.69 | — | — |
| 2025 | $0.09 | −$2.70 | $0.00 | −$1.83 | — | $0.07 |